🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Earlier Detection and Optimization of Treatment and Prognosis for Patients With Early-onset Colorectal Cancer

Recruitingn/aAges 18 Years - 49 YearsAllThe Netherlands Cancer Institute
NCT06568679 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study aims to collect high quality clinical data on lifestyle and patient biomaterials prior to start or during / after treatment of early-onset colorectal cancer (EOCRC) and to inform on treatment and survival outcomes of EOCRC patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with locoregional or metastatic colorectal cancer (CRC) * Histologically proven CRC * Age 18 - 49 years at time of first CRC diagnosis * Able to understand the informed consent form * Provide written informed consent. Exclusion Criteria: * Mentally incompetent patients based on the opinion of treating physician * Inability to understand the Dutch language
💊

What it tests

  • No intervention; observational
📍

Where

1 site
Netherlands Cancer Institute
Amsterdam, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy